Severe Kawasaki disease in infants: Two fatal cases

Canadian Journal of Cardiology

Volumn 16, Issue 8, 2000, Pages 1017-1023

  Brenner, J L ^a   Jadavji, T ^a   Pinto, A ^a   Trevenen, C ^a   Patton, D ^a  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Aneurysm; Coronary disease; Ischemia; Kawasaki disease; Pediatrics

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CORTICOSTEROID; IMMUNOGLOBULIN;

ANEURYSM; ARTICLE; CASE REPORT; CHOLANGITIS; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FATALITY; FEMALE; GANGRENE; HEART INFARCTION; HUMAN; INFANT; INFLAMMATORY DISEASE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE ORGAN FAILURE; PATHOLOGY; THROMBOSIS; VASCULITIS;

ANEURYSM; ARM; CASE REPORT; FATAL OUTCOME; FEMALE; GANGRENE; HUMAN; INFANT; LEG; LIVER; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDIUM;

EID: 0033832272     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children
2. Atypical Kawasaki disease: Analysis of clinical presentation and diagnostic clues
3. Atypical and complicated Kawasaki disease in infants: Do we need criteria?
4. Clinical spectrum of Kawasaki disease in infants younger than 6 months of age
5. Kawasaki syndrome
6. The treatment of Kawasaki syndrome with intravenous gamma globulin
7. Hydrocele in Kawasaki disease: Importance in early recognition of atypical disease
8. Kawasaki disease: With particular emphasis on arterial lesions
9. Pathology of Kawasaki disease: 1. Pathology and morphogenesis of the vascular changes
10. Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease
11. Atypical Kawasaki disease with peripheral gangrene and myocardial infarction: Therapeutic implications
12. Peripheral gangrene associated with Kawasaki disease
13. Kawasaki disease complicated by peripheral gangrene
14. Hepatomegaly and splenomegaly in Kawasaki disease
15. General pathology of Kawasaki disease: On the morphological alterations corresponding to the clinical manifestations
16. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki disease
17. Gamma globulin re-treatment in Kawasaki disease
18. Comparison of low dose aspirin vs high dose aspirin as an adjunct to IVIG in Kawasaki syndrome
19. The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment
20. Treatment of Kawasaki disease: Corticosteroids revisited
21. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction
22. Kawasaki disease
23. Effect of dipyridamole in the blood flow in coronary aneurysms resulting from Kawasaki disease
24. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
25. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease
26. Guidelines for long-term management of patients with Kawasaki disease: Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
27. The use of low molecular weight heparin for the treatment of giant aneurysms in Kawasaki disease
28. Antithrombotic therapy in children
29. Kawasaki disease: Effect of treatment on coronary artery involvement
30. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids
31. Corticosteroids in the treatment of the acute phase of Kawasaki disease
32. Report of the National Institutes of Health Workshop on Kawasaki Disease